Status:
COMPLETED
Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam
Lead Sponsor:
International Vaccine Institute
Collaborating Sponsors:
National Institute of Hygiene and Epidemiology, Vietnam
Hue Preventive Medicine Center, Vietnam
Conditions:
Typhoid
Paratyphoid Fever
Eligibility:
All Genders
5-18 years
Phase:
PHASE4
Brief Summary
This study is part of International Vaccine Institutes (IVI)'s typhoid Vi demonstration project that aims to accelerate the rational introduction of Vi vaccines in typhoid endemic countries. The prima...
Detailed Description
Typhoid fever is a major cause of morbidity worldwide. The disease predominantly affects school-aged children, is more prevalent in urban areas, may last for several weeks and can lead to serious comp...
Eligibility Criteria
Inclusion
- Local students whose parents/guardians provide written consent to receive Vi vaccine
- Attending any of the 66 registered schools in Hue
- Registered in the project census
- Lives in Hue City
Exclusion
- Fever (\>37.5 degrees Celsius, axillary)
- Pregnancy
- Lactating
Key Trial Info
Start Date :
December 1 2001
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
100742 Patients enrolled
Trial Details
Trial ID
NCT00131820
Start Date
December 1 2001
End Date
January 1 2007
Last Update
March 13 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Hygiene and Epidemiology
Hanoi, Vietnam